Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1/2 Study of ML-016 in Participants With Advanced Cancer With Lung and/or Liver Involvement

NCT07723482 is registered in ClinicalTrials.gov with BrYet US, Inc. as lead sponsor.

NCT NCT07723482
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07723482 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1/2 Study of ML-016 in Participants With Advanced Cancer With Lung and/or Liver Involvement
Lead sponsor
BrYet US, Inc.
Phase
Phase 1/2
Overall status
Recruiting
Start date
September 25, 2026
Completion date
October 31, 2030
Enrollment
108 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumor with lung and/or liver involvement